Immune Checkpoint Inhibitors (ICI)-Related Dermatitis Clinical Trials in Quzhou, Zhejiang

JAK Inhibitors for Solid Malignant Tumor Patients With Immune Checkpoint Inhibitors-related Dermatitis: A Open-lable, Single Arm, Phase IIa Trial